This report provides comprehensive information on the current therapeutic developmental pipeline of Momenta Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Get Detail Report With TOC @ http://www.researchmoz.us/momenta-pharmaceuticals-inc-product-pipeline-review-2014-report.html The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

1. Momenta Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Momenta Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Summary
Global Markets Directs, Momenta Pharmaceuticals, Inc. - Product Pipeline Review - 2014, provides an overview of the Momenta Pharmaceuticals, Inc.s
pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Momenta Pharmaceuticals, Inc.s, complete with
comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It
also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides brief overview of Momenta Pharmaceuticals, Inc. including business description, key information and facts, and its locations and
subsidiaries
- The report reviews current pipeline of Momenta Pharmaceuticals, Inc.s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major
milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Momenta Pharmaceuticals, Inc.s pipeline products
Reasons to buy
- Evaluate Momenta Pharmaceuticals, Inc.s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Momenta Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Momenta Pharmaceuticals, Inc.s R&D portfolio and develop key strategic initiatives to reinforce
pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Momenta Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Momenta Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand
business potential and scope
- Explore the dormant and discontinued projects of Momenta Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 4
momenta Pharmaceuticals, Inc. Snapshot 5
momenta Pharmaceuticals, Inc. Overview 5
key Information 5
key Facts 5
momenta Pharmaceuticals, Inc. - Research And Development Overview 6
key Therapeutic Areas 6
momenta Pharmaceuticals, Inc. - Pipeline Review 9
pipeline Products By Stage Of Development 9
pipeline Products - Monotherapy 10
pipeline Products - Partnered Products 11
Momenta Pharmaceuticals, Inc. - Product Pipeline Review - 2014

2. partnered Products/combination Treatment Modalities 12
momenta Pharmaceuticals, Inc. - Pipeline Products Glance 13
momenta Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 13
phase I Products/combination Treatment Modalities 13
momenta Pharmaceuticals, Inc. - Early Stage Pipeline Products 14
preclinical Products/combination Treatment Modalities 14
discovery Products/combination Treatment Modalities 15
momenta Pharmaceuticals, Inc. - Drug Profiles 16
m-402 16
product Description 16
mechanism Of Action 16
r&d Progress 16
antibody For Autoimmune Disorders And Inflammation 17
product Description 17
mechanism Of Action 17
r&d Progress 17
m-834 18
product Description 18
mechanism Of Action 18
r&d Progress 18
m-923 19
product Description 19
mechanism Of Action 19
r&d Progress 19
m-511 20
product Description 20
mechanism Of Action 20
r&d Progress 20
momenta Pharmaceuticals, Inc. - Pipeline Analysis 21
momenta Pharmaceuticals, Inc. - Pipeline Products By Target 21
momenta Pharmaceuticals, Inc. - Pipeline Products By Molecule Type 22
momenta Pharmaceuticals, Inc. - Pipeline Products By Mechanism Of Action 23
momenta Pharmaceuticals, Inc. - Recent Pipeline Updates 24
momenta Pharmaceuticals, Inc. - Dormant Projects 25
momenta Pharmaceuticals, Inc. - Company Statement 26
momenta Pharmaceuticals, Inc. - Locations And Subsidiaries 31
head Office 31
other Locations & Subsidiaries 31
appendix 32
methodology 32
coverage 32
secondary Research 32
primary Research 32
expert Panel Validation 32
contact Us 33
disclaimer 33
list Of Tables
momenta Pharmaceuticals, Inc., Key Information 5
momenta Pharmaceuticals, Inc., Key Facts 5
momenta Pharmaceuticals, Inc. - Pipeline By Indication, 2014 8
momenta Pharmaceuticals, Inc. - Pipeline By Stage Of Development, 2014 9
momenta Pharmaceuticals, Inc. - Monotherapy Products In Pipeline, 2014 10
momenta Pharmaceuticals, Inc. - Partnered Products In Pipeline, 2014 11
momenta Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2014 12
momenta Pharmaceuticals, Inc. - Phase I, 2014 13
momenta Pharmaceuticals, Inc. - Preclinical, 2014 14
momenta Pharmaceuticals, Inc. - Discovery, 2014 15
momenta Pharmaceuticals, Inc. - Pipeline By Target, 2014 21
momenta Pharmaceuticals, Inc. - Pipeline By Molecule Type, 2014 22
momenta Pharmaceuticals, Inc. - Pipeline Products By Mechanism Of Action, 2014 23
momenta Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 24
momenta Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 25
momenta Pharmaceuticals, Inc., Subsidiaries 31
list Of Figures
momenta Pharmaceuticals, Inc. - Pipeline By Top 10 Indication, 2014 7
momenta Pharmaceuticals, Inc. - Pipeline By Stage Of Development, 2014 9
Momenta Pharmaceuticals, Inc. - Product Pipeline Review - 2014

3. momenta Pharmaceuticals, Inc. - Monotherapy Products In Pipeline, 2014 10
momenta Pharmaceuticals, Inc. - Pipeline By Top 10 Target, 2014 21
momenta Pharmaceuticals, Inc. - Pipeline By Top 10 Molecule Type, 2014 22
momenta Pharmaceuticals, Inc. - Pipeline Products By Top 10 Mechanism Of Action, 2014 23
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Momenta Pharmaceuticals, Inc. - Product Pipeline Review - 2014